CSF Alzheimer's disease-like pattern in corticobasal syndrome: Evidence for a distinct disorder

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 82, Issue 8, 2011, Pages 834-838

  Borroni, Barbara ^a   Premi, Enrico ^a   Agosti, Chiara ^a   Alberici, Antonella ^a   Cerini, Carlo ^a   Archetti, Silvana ^b   Lanari, Alessia ^c   Paghera, Barbara ^a   Lucchini, Silvia ^a   Caimi, Luigi ^b   Padovani, Alessandro ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b Brescia Civic Hospital   (Italy)

^c Hospital of Mantova   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALZHEIMER DISEASE; APRAXIA; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; COGNITIVE DEFECT; CORTICOBASAL SYNDROME; DEMOGRAPHY; EXTRAPYRAMIDAL SYNDROME; FEMALE; HIPPOCAMPUS; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; LANGUAGE DISABILITY; MALE; MEMORY DISORDER; NEUROLOGIC DISEASE; NEUROPSYCHOLOGICAL TEST; PHENOTYPE; POSTERIOR CINGULATE; PRECUNEUS; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BASAL GANGLIA; BIOLOGICAL MARKERS; CEREBRAL CORTEX; FEMALE; HUMANS; MALE; MIDDLE AGED; NEURODEGENERATIVE DISEASES; NEUROPSYCHOLOGICAL TESTS; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; SYNDROME; TAU PROTEINS; TECHNETIUM TC 99M EXAMETAZIME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 79960150490     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2010.221853     Document Type: Article

References (27)

1. Rebeiz JJ, Kolodny EH, Richardson EP Jr. Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol 1968;18:20-33.
2. Lang AE. Corticobasal degeneration: selected developments. Mov Disord 2003;18:S51-6.
3. Litvan I, Bhatia KP, Burn DJ, et al. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 2003;18:467-86. (Pubitemid 36656531)
4. Boeve BF, Maraganore DM, Parisi JE, et al. Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology 1999;53:795-800. (Pubitemid 29448302)
5. Ball JA, Lantos PL, Jackson M, et al. Alien hand sign in association with Alzheimer's histopathology. J Neurol Neurosurg Psychiatry 1993;56:1020-3. (Pubitemid 23272396)
6. Green RC, Goldstein FC, Mirra SS, et al. Slowly progressive apraxia in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1995;59:312-15.
7. Doran M, du Plessis DG, Enevoldson TP, et al. Pathological heterogeneity of clinically diagnosed corticobasal degeneration. J Neurol Sci 2003;216:127-34. (Pubitemid 37371877)
8. Chand P, Grafman J, Dickson D, et al. Alzheimer's disease presenting as corticobasal syndrome. Mov Disord 2006;21:2018-22. (Pubitemid 44848961)
9. Shelley BP, Hodges JR, Kipps CM, et al. Is the pathology of corticobasal syndrome predictable in life? Mov Disord 2009;24:1593-9.
10. Hu WT, Rippon GW, Boeve BF, et al. Alzheimer's disease and corticobasal degeneration presenting as corticobasal syndrome. Mov Disord 2009;24:1375-9.
11. Mattsson N, Zetterberg H, Hansson O, et al. CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA 2009;302:385-93.
12. Visser PJ, Verhey F, Knol DL, et al. Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study. Lancet Neurol 2009;8:619-27.
13. Dubois B, Feldman HH, Jacova C, et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007;6:734-46. (Pubitemid 47058377)
14. De Renzi E, Motti F, Nichelli P. Imitating gestures. A quantitative approach to ideomotor apraxia. Arch Neurol 1980;37:6-10.
15. Fahn S, Elton RL. Members of the UPDRS development committee. Unified Parkinson's Disease rating Scale. Florham Park, NJ: MacMillan Healthcare Information, 1987:153-304.
16. Cummings JL, Mega M, Gray K, et al. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308-14. (Pubitemid 24382728)
17. Kertesz A, Nadkarni N, Davidson W, et al. The Frontal Behavioral Inventory in the differential diagnosis of frontotemporal dementia. J Int Neuropsychol Soc 2000;6:460-8. (Pubitemid 30394399)
18. Bian H, Van Swieten JC, Leight S, et al. CSF biomarkers in frontotemporal lobar degeneration with known pathology. Neurology 2008;70:1827-35. (Pubitemid 351653951)
19. Urakami K, Wada K, Arai H, et al. Diagnostic significance of tau protein in cerebrospinal fluid from patients with corticobasal degeneration or progressive supranuclear palsy. J Neurol Sci 2001;183:95-8. (Pubitemid 32141077)
20. Paraskevas GP, Kapaki E, Liappas I, et al. The diagnostic value of cerebrospinal fluid tau protein in dementing and nondementing neuropsychiatric disorders. J Geriatr Psychiatry Neurol 2005;18:163-73. (Pubitemid 41284967)
21. Arai H, Morikawa Y, Higuchi M, et al. Cerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology. Biochem Biophys Res Commun 1997;236:262-4. (Pubitemid 27373280)
22. Borroni B, Malinverno M, Gardoni F, et al. Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy. Neurology 2008;71:1796-803.
23. Noguchi M, Yoshita M, Matsumoto Y, et al. Decreased beta-amyloid peptide42 in cerebrospinal fluid of patients with progressive supranuclear palsy and corticobasal degeneration. J Neurol Sci 2005;237:61-5. (Pubitemid 41384015)
24. Litvan I, Agid Y, Goetz C, et al. Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. Neurology 1997;48:119-25. (Pubitemid 27039529)
25. Alladi S, Xuereb J, Bak T, et al. Focal cortical presentations of Alzheimer's disease. Brain 2007;130:2636-45. (Pubitemid 47511719)
26. Okazaki K, Fu YJ, Nishihira Y, et al. Alzheimer's disease: report of two autopsy cases with a clinical diagnosis of corticobasal degeneration. Neuropathology 2010;30:140-8.
27. Anchisi D, Borroni B, Franceschi M, et al. Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease. Arch Neurol 2005;62:1728-33. (Pubitemid 41626670)